|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F Floor, School of Medicine and Biomedical Sciences, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK
Correspondence
Mark S. Thomas
m.s.thomas{at}sheffield.ac.uk
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The factor for inversion stimulation (FIS) regulates transcription by binding to highly degenerate 15 bp DNA sequences (Finkel & Johnson, 1992
; Ross et al., 1999
). At some E. coli promoters, FIS activates transcription by contacting the C-terminal domain of the RNA polymerase (RNAP)
subunit (
CTD) (Aiyar et al., 2002
; McLeod et al., 2002
). FIS can also promote transcription by decreasing the negative superhelicity of DNA (Travers et al., 2001
). At other promoters, FIS downregulates promoter activity by binding to a site that overlaps or is located downstream from the RNAP binding site, or by forming a complex assembly with other nucleoid proteins (Gonzalez-Gil et al., 1998
; Browning et al., 2000
, 2004
; Jackson et al., 2004
). A previous study identified four putative binding sites for FIS that are located upstream of the PguaB core promoter region (Hutchings & Drabble, 2000
). The putative FIS binding sites are centred near positions –77, –92, –109 and –126 relative to the guaB transcription start, and were referred to as FIS sites I–IV, respectively (Fig. 1a
). FIS contributes to GRDC of the thrU and pdxA promoters, and is required for growth rate-dependent synthesis of 4.5S RNA,
and
(Emilsson & Nilsson, 1995
; Dong et al., 1996
). Moreover, transcription from the fis promoter is coupled to cellular growth rate (Mallik et al., 2006
). Cellular levels of FIS and FIS mRNA also change with the growth phase, and they increase dramatically upon entry into the mid-exponential growth phase (Appleman et al., 1998
; Ali Azam et al., 1999
; Mallik et al., 2006
).
|
| METHODS |
|---|
|
|
|---|
prophage and were constructed using a system based on
imm21 (Simons et al., 1987
fis was made by introducing the fis : : aadA allele from strain JCB38841 (Ball et al., 1992
fis was made by introducing the same allele into VH1000G-69. All plasmids contain PguaB derivatives that were inserted as EcoRI–HindIII fragments. Plasmids pBSG-253 and pBSG-133 are derivatives of pBluescript II KS containing the promoters PguaB (–253 to +36) and PguaB (–133 to +36), respectively. pUCG-253 is a derivative of pUC19 containing PguaB (–253 to +36). The plasmid pRLG770 has been described previously (Ross et al., 1990
DNase I footprinting.
The EcoRI–XhoI DNA fragment in pBSG-253 was purified following electrophoresis in a 6 % acrylamide gel (Meng et al., 2000
), labelled at the downstream (XhoI) end with [
-32P]ATP [>7000 Ci (2.59x1014 Bq) mmol–1, MP Biomedicals] and subsequently purified according to a published procedure (Husnain & Thomas, 2008
). The EcoRI–XhoI fragment in pBSG-133 was labelled similarly at the upstream end. Labelled DNA fragment (4 nM) was incubated at room temperature for 30 min in a volume of 20 µl containing 20 mM HEPES (pH 8.0), 5 mM MgCl2, 50 mM potassium glutamate, 1 mM DTT, 20 µg ml–1 sonicated calf thymus DNA (GE Healthcare) and 5 % (v/v) glycerol, in the absence or presence of purified FIS protein. Purified FIS was a generous gift from T. Gaal and R. L. Gourse (University of Wisconsin–Madison). DNase I footprinting and DNA fragment separation were performed exactly as described previously (Husnain & Thomas, 2008
). Footprints were visualized using a FujiFilm FLA3000 phosphorimager.
Electromobility shift assay (EMSA).
A DNA fragment containing PguaB (–253 to +36) was amplified by PCR from pUCG-253, using primers pUC19(for) (5'-ACGTTGTAAAACGACGGCCAG-3') and pUC19(rev) (5'-GCGCGGATCCATGACCATGATTACGCCAAGCT-3'). A DNA fragment containing the rrnB P1 promoter with FIS site I (positions –87 to +50 relative to the rrnB P1 transcription start site) and an rrnB P1 promoter derivative that did not contain a FIS site (positions –37 to +52 relative to the rrnB P1 transcription start site, and containing non-rrnB P1 sequences upstream to position –92) were PCR amplified from plasmids pRLG1616 and pRLG4720, respectively, using a forward primer with the sequence 5'-GTATCACGAGGCCCT-3' and reverse primer RLG1620 (5'-GCGCTACGGCGTTTCACTTC-3'), both of which are vector-specific (Newlands et al., 1991
; Ross et al., 1998
; Meng et al., 2001
). PCR products were digested with HindIII, and purified following electrophoresis in a 6 % acrylamide gel (Meng et al., 2000
). Fragments were labelled at the HindIII end using [
-32P]dATP [3000 Ci (1.11x1014 Bq) mmol–1, MP Biomedicals] and DNA polymerase I Klenow fragment. Labelled DNA (final concentration 0.4 nM) was incubated at room temperature for 30 min in a volume of 10 µl containing 20 mM HEPES (pH 8.0), 5 mM MgCl2, 50 mM potassium glutamate, 1 mM DTT, 10 % (v/v) glycerol and 20 µg ml–1 sonicated calf thymus DNA (GE Healthcare), in the absence or presence of different concentrations of FIS. Samples were loaded (under tension) onto a 6 % acrylamide gel (37.5 : 1 acrylamide : bis acrylamide) containing 7.5 % (v/v) glycerol while running at
15 V cm–1, and gels were run for
1 h at 4 °C. Radiolabelled DNA was visualized using a FujiFilm FLA3000 phosphorimager.
Measurement of transcription in vitro.
Multiple-round transcription reactions were performed as described previously, using supercoiled pRLG770 derivatives containing PguaB fragments (Husnain & Thomas, 2008
). As a control, transcription was also measured from an rrnB P1 promoter derivative that did not contain any FIS sites (plasmid pRLG4238; Estrem et al., 1998
). FIS (250 nM) was incubated with DNA in reaction buffer at room temperature for 30 min. Transcription was initiated at 30 °C with 10 nM E. coli RNAP holoenzyme (Epicentre), and reactions were allowed to proceed for 20 min.
Measurement of transcription in vivo.
Strains containing a chromosomally integrated PguaB-lacZ transcriptional fusion were employed in the measurement of promoter activity in vivo. Cells were inoculated from dense starter cultures into media that supported different cellular growth rates, as described previously (Husnain & Thomas, 2008
). The β-galactosidase activity was determined following disruption of cells by sonication (Miller, 1972
). To measure promoter activity at different stages of the growth cycle, cells were grown overnight in M9 minimal medium with 0.4 % (w/v) glucose, 0.8 % (w/v) Casamino acids and 5 µg thiamine ml–1, and inoculated into fresh medium to an OD600 of
0.01. Growth was monitored at OD600, and the β-galactosidase activity was measured at different points on the growth curve after cells were permeabilized with chloroform-SDS (Miller, 1972
).
| RESULTS |
|---|
|
|
|---|
Using this approach, no sites were identified that contained the most highly conserved base at all five critical positions. However, we identified nine candidate FIS binding sites that contained the most highly conserved base at 4/5 critical positions (Fig. 1b
). All of these sites contained the consensus A or T base at the central position (position 0) and the conserved T residue at position +3. These sequences were subdivided into three categories. Category 1 sites contain bases that match the consensus at 4/5 critical positions, including the outer bases (positions –7 and +7) that are most strongly conserved among FIS sites and which are presumed to be bound by the D helices of FIS (Shultzaberger et al., 2007
). The remaining critical position (position –3) contained the alternative purine base G that occurred less frequently at that position. Two candidate FIS sites were identified that fell into this category (Fig. 1b
). Category 2 sites differ from category 1 sites in having a less frequently occurring C or T residue at position –3. Two additional sites fell into this category. Category 3 sites also contain bases that match the consensus at 4/5 critical positions. However, the mismatches occur at one of the highly conserved bases that are located at the outermost positions. Five sequences were classified as category 3 sites (Fig. 1b
). Two of them correspond to the previously identified putative FIS sites III and IV located upstream of PguaB (Hutchings & Drabble, 2000
). Putative FIS sites I and II were not identified by this analysis as they harbour bases that match the consensus at only 3/5 of the critical positions, although they do include non-consensus but frequently occurring bases at the remaining two critical positions (positions –3 and +3) (Fig. 1b
).
Analysis of FIS binding to PguaB
EMSA was employed to determine whether FIS can bind to a DNA fragment containing the guaB promoter. As a comparison, binding of FIS to the rrnB P1 promoter, which is known to bind FIS under physiological conditions, was also analysed. The rrnB P1 promoter fragment employed contained the promoter-proximal FIS site, i.e. FIS site I (Ross et al., 1990
; Bokal et al., 1995
). The minimum concentration of FIS required to observe FIS–DNA interactions at either PguaB (–253 to +36) or the rrnB P1 fragment by EMSA was 50 nM. Increasing the FIS concentration to 300 nM resulted in the formation of three different complexes between FIS and PguaB (Fig. 2
). At this concentration of FIS, a larger fraction of the rrnB P1 promoter fragment was bound by FIS, but there remained only a single FIS–DNA complex, and no FIS–DNA complexes were observed at an rrnB P1 promoter derivative that lacked a FIS site (Fig. 2
). At a FIS concentration of 500 nM, an additional FIS–DNA complex was observed at both PguaB and rrnB P1 harbouring FIS site I. As a complex was also observed with the promoter fragment that did not contain a FIS site, it is likely that the additional FIS–DNA interactions observed at 500 nM FIS are non-specific (Fig. 2
). These results indicate that FIS binds to at least three sites at or near PguaB under similar conditions to those in which FIS specifically binds to rrnB P1, and thereby suggest that FIS is likely to bind to these sites under physiological conditions.
|
|
8–10-fold repression of transcription from PguaB (–253 to +36). Under the same conditions, there was no repressive effect of FIS on transcription from the rrnB P1 promoter (Fig. 4a, b
|
|
In accordance with the results of the GRDC experiment, the activity of PguaB was higher in the fis background than in the wild-type strain throughout the course of the growth cycle. In the wild-type strain, PguaB activity increased by nearly 40 % as cells entered the mid-exponential growth phase (i.e. the promoter activity at an OD600 of
0.15–0.20 was 40 % higher than the activity at an OD600 of
0.012). The increase in activity in a fis strain over the corresponding part of the growth curve was less marked (i.e. there was a
16 % increase in promoter activity). Upon entry into stationary phase, there was a gradual decrease in the promoter activity in both strain backgrounds (Fig. 6
). The results suggest that PguaB is subject to a degree of growth-phase-dependent regulation. However, there was no significant change in the transcription activity profile during the growth cycle when comparing the two strain backgrounds. Furthermore, PguaB activity peaks at the time that FIS levels are expected to be at their highest, and then falls off upon entry into stationary phase when FIS levels fall (Appleman et al., 1998; Ali Azam et al., 1999
). These observations suggest that FIS does not significantly influence growth phase-dependent regulation of PguaB under the conditions employed.
|
| DISCUSSION |
|---|
|
|
|---|
At the tyrT promoter, FIS binding to sites II and III (centred at positions –91 and –122, respectively) cooperatively affects the binding of FIS to site I centred at –71 bp upstream of the transcription start site (Lazarus & Travers, 1993
; Pemberton et al., 2002
). As the B-form of DNA has a periodicity of 10.6 bp, this places these three sites on the same face of the DNA helix, with the centres of sites I and II separated by 21 bp. This suggests that cooperative interactions require adjacent FIS dimers to be positioned on the same face of the DNA, two turns of the DNA helix apart. At the rrnB P1 promoter, FIS sites I–III are centred at positions –71, –102 and –143, respectively, also placing them approximately on the same face of the DNA helix. However, FIS does not bind to rrnB P1 cooperatively in the absence of RNAP, and it is noteworthy that the central positions of these sites are separated by 32 or 42 bp (i.e. not 21 bp). Interestingly, at PguaB, FIS sites 2 and 3 are positioned 22 bp apart (centre to centre) which will also place them on the same face of the DNA helix and a similar distance apart as FIS sites I and II at the tyrT promoter. However, the centres of FIS sites 1 and 2 at PguaB are 18 bp apart, making it unlikely that they are located on the same face of the DNA. Therefore, it is possible that FIS binds cooperatively to sites 2 and 3, but it appears less likely that occupancy of sites 2 and/or 3 stimulates binding of FIS to site 1.
Consistent with the location of functional FIS sites, we show that FIS represses transcription from PguaB
8–10-fold in vitro. Deletion of FIS site 3 results in partial relief of repression, and deletion of FIS sites 2 and 3 together further relieves repression in vitro. The residual FIS-mediated repression of the guaB promoter fragment containing the +1 downstream end point is likely to occur through interactions with site 1, and would suggest that binding of to site 1 does not require cooperative interactions with FIS dimers bound to adjacent sites. The binding of FIS to site 1 is likely to sterically hinder the recruitment of RNAP to PguaB, as observed at the crp1 promoter (Gonzalez-Gil et al., 1998
). The role of FIS sites 2 and 3, which together exert the most influence on transcription from PguaB in vitro, is less clear, although it is likely that the role of FIS site 3 is to stimulate binding of FIS to site 2, which in turn may play more of a direct role in repression. Our results suggest that the presence of FIS should decrease RNAP binding to PguaB. However, DNase I footprinting experiments carried out in the presence of both FIS and RNAP were inconclusive (data not shown).
Although our results demonstrate that FIS represses transcription from PguaB in vitro, evidence for direct repression by FIS in vivo was not obtained (i.e. deletion of FIS sites 2 and 3 did not result in increased PguaB activity in wild-type exponentially growing cells). This is consistent with the results of a chromatin immunoprecipitation (ChIP)-chip analysis carried out under similar conditions, in which FIS binding at PguaB was not detected (see supplementary data in Grainger et al., 2006
). However, in a fis strain we observed an increase in the activity of the guaB promoter in derivatives containing all three FIS sites in the presence (PguaB (–253 to +36)) or absence [PguaB (–69 to +36)] of the putative CRP site centred at –117.5. This rules out the possibility that the effect of deleting fis on guaB promoter activity is mediated by changes in CRP abundance [FIS has been shown to modulate transcription of crp (Gonzalez-Gil et al., 1998
)]. However, it is possible that the change in transcription activity of PguaB in a fis background occurs as a result of altered regulation of PguaB by a transcription factor other than CRP, for example H-NS or HU (Claret & Rouviere-Yaniv, 1996
; Falconi et al., 1996
) or by changes in supercoiling (Schneider et al., 1997
; Weinstein-Fischer et al., 2000
). Another possible explanation is that the potential relief of PguaB repression that occurs upon deleting FIS sites 2 and 3 is masked in vivo through an alternative compensatory regulatory mechanism. A less likely explanation, in view of the poor match to the consensus FIS binding site, is that FIS binding to site 1 mediates full FIS-mediated repression in vivo.
A previous study has shown that the PguaB UP element, and sequences located further upstream, are required for GRDC of PguaB (Husnain & Thomas, 2008
). Our results show that FIS does not play a role in GRDC at this promoter, thereby implying that a different cellular factor is required for conferring GRDC on PguaB (Emilsson & Nilsson, 1995
; Dennis et al., 2004
; Paul et al., 2004
). Experiments are under way to uncover the identity of this factor(s). Our results also suggest that PguaB is subject to growth phase-dependent control. However, although levels of FIS protein are also subject to growth phase-dependent control, it does not appear to play an important role in growth phase-dependent control at PguaB. Thus, the physiological role of FIS at the guaB promoter remains to be elucidated.
| ACKNOWLEDGEMENTS |
|---|
Edited by: L. S. Frost
| REFERENCES |
|---|
|
|
|---|
Ali Azam, T., Iwata, A., Nishimura, A., Ueda, S. & Ishihama, A. (1999). Growth phase-dependent variation in protein composition of the Escherichia coli nucleoid. J Bacteriol 181, 6361–6370.
Appleman, J. A., Ross, W., Salomon, J. & Gourse, R. L. (1998). Activation of Escherichia coli rRNA transcription by FIS during a growth cycle. J Bacteriol 180, 1525–1532.
Ball, C. A., Osuna, R., Ferguson, K. C. & Johnson, R. C. (1992). Dramatic changes in Fis levels upon nutrient upshift in Escherichia coli. J Bacteriol 174, 8043–8056.
Bokal, A. J., Ross, W. & Gourse, R. L. (1995). The transcriptional activator protein FIS: DNA interactions and cooperative interactions with RNA polymerase at the Escherichia coli rrnB P1 promoter. J Mol Biol 245, 197–207.[CrossRef][Medline]
Bradley, M. D., Beach, M. B., de Koning, A. P., Pratt, T. S. & Osuna, R. (2007). Effects of FIS on Escherichia coli gene expression during different growth stages. Microbiology 153, 2922–2940.
Browning, D. F., Cole, J. A. & Busby, S. J. (2000). Suppression of FNR-dependent transcription activation at the Escherichia coli nir promoter by Fis, IHF and H-NS: modulation of transcription initiation by a complex nucleo-protein assembly. Mol Microbiol 37, 1258–1269.[CrossRef][Medline]
Browning, D. F., Beatty, C. M., Sanstad, E. A., Gunn, K. E., Busby, S. J. W. & Wolfe, A. J. (2004). Modulation of CRP-dependent transcription at the Escherichia coli acsP2 promoter by nucleoprotein complexes: anti-activation by the nucleoid proteins FIS and IHF. Mol Microbiol 51, 241–254.[CrossRef][Medline]
Claret, L. & Rouviere-Yaniv, J. (1996). Regulation of HU alpha and HU beta by CRP and FIS in Escherichia coli. J Mol Biol 263, 126–139.[CrossRef][Medline]
Davies, I. J. & Drabble, W. T. (1996). Stringent and growth-rate-dependent control of the gua operon of Escherichia coli K-12. Microbiology 142, 2429–2437.[Abstract]
Dennis, P. P., Ehrenberg, M. & Bremer, H. (2004). Control of rRNA synthesis in Escherichia coli: a systems biology approach. Microbiol Mol Biol Rev 68, 639–668.
Dong, H., Kirsebom, L. A. & Nilsson, L. (1996). Growth rate regulation of 4.5 S RNA and M1 RNA the catalytic subunit of Escherichia coli RNase P. J Mol Biol 261, 303–308.[CrossRef][Medline]
Emilsson, V. & Nilsson, L. (1995). Factor for inversion stimulation-dependent growth rate regulation of serine and threonine tRNA species. J Biol Chem 270, 16610–16614.
Estrem, S. T., Gaal, T., Ross, W. & Gourse, R. L. (1998). Identification of an UP element consensus sequence for bacterial promoters. Proc Natl Acad Sci U S A 95, 9761–9766.
Falconi, M., Brandi, A., La Teana, A., Gualerzi, C. O. & Pon, C. L. (1996). Antagonistic involvement of FIS and H-NS proteins in the transcriptional control of hns expression. Mol Microbiol 19, 965–975.[CrossRef][Medline]
Finkel, S. E. & Johnson, R. C. (1992). The Fis protein: it's not just for DNA inversion anymore. Mol Microbiol 6, 3257–3265.[Medline]
Gonzalez-Gil, G., Kahmann, R. & Muskhelishvili, G. (1998). Regulation of crp transcription by oscillation between distinct nucleoprotein complexes. EMBO J 17, 2877–2885.[CrossRef][Medline]
Gourse, R. L., Gaal, T., Bartlett, M. S., Appleman, J. A. & Ross, W. (1996). rRNA transcription and growth rate-dependent regulation of ribosome synthesis in Escherichia coli. Annu Rev Microbiol 50, 645–677.[CrossRef][Medline]
Grainger, D. C., Hurd, D., Goldberg, M. D. & Busby, S. J. W. (2006). Association of nucleiod proteins with coding and non-coding segments of the Escherichia coli genome. Nucleic Acids Res 34, 4642–4652.
Hengen, P. N., Bartram, S. L., Stewart, L. E. & Schneider, T. D. (1997). Information analysis of Fis binding sites. Nucleic Acids Res 25, 4994–5002.
Husnain, S. I. & Thomas, M. S. (2008). The UP element is necessary but not sufficient for growth rate-dependent control of the Escherichia coli guaB promoter. J Bacteriol 190, 2450–2457.
Hutchings, M. I. & Drabble, W. T. (2000). Regulation of the divergent guaBA and xseA promoters of Escherichia coli by the cyclic AMP receptor protein. FEMS Microbiol Lett 187, 115–122.[CrossRef][Medline]
Jackson, L., Blake, T. & Green, J. (2004). Regulation of ndh expression in Escherichia coli by Fis. Microbiology 150, 407–413.
Lazarus, L. R. & Travers, A. A. (1993). The Escherichia coli FIS protein is not required for the activation of tyrT transcription on entry into exponential growth. EMBO J 12, 2483–2494.[Medline]
Mallik, P., Paul, B. J., Rutherford, S. T., Gourse, R. L. & Osuna, R. (2006). DksA is required for growth phase-dependent regulation, growth rate-dependent control, and stringent control of fis expression in Escherichia coli. J Bacteriol 188, 5775–5782.
McLeod, S. M., Aiyar, S. E., Gourse, R. L. & Johnson, R. C. (2002). The C-terminal domains of the RNA polymerase
subunits: contact site with Fis and localization during co-activation with CRP at the Escherichia coli proP P2 promoter. J Mol Biol 316, 517–529.[CrossRef][Medline]
Mehra, R. K. & Drabble, W. T. (1981). Dual control of the gua operon of Escherichia coli K12 by adenine and guanine nucleotides. J Gen Microbiol 123, 27–37.[Medline]
Meng, L. M., Kilstrup, M. & Nygaard, P. (1990). Autoregulation of PurR repressor synthesis and involvement of purR in the regulation of purB, purC, purL, purMN and guaBA expression in Escherichia coli. Eur J Biochem 187, 373–379.[Medline]
Meng, W., Savery, N. J., Busby, S. J. W. & Thomas, M. S. (2000). The Escherichia coli RNA polymerase
subunit linker: length requirements for transcription activation at CRP-dependent promoters. EMBO J 19, 1555–1566.[CrossRef][Medline]
Meng, W., Belyaeva, T., Savery, N. J., Busby, S. J., Ross, W. E., Gaal, T., Gourse, R. L. & Thomas, M. S. (2001). UP element-dependent transcription at the Escherichia coli rrnB P1 promoter: positional requirements and role of the RNA polymerase alpha subunit linker. Nucleic Acids Res 29, 4166–4178.
Miller, J. (1972). Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Newlands, J. T., Ross, W., Gosink, K. K. & Gourse, R. L. (1991). Factor-independent activation of Escherichia coli rRNA transcription. II. characterization of complexes of rrnB P1 promoters containing or lacking the upstream activator region with Escherichia coli RNA polymerase. J Mol Biol 220, 569–583.[CrossRef][Medline]
Nilsson, L., Verbeek, H., Vijgenboom, E., van-Drunen, C., Vanet, A. & Bosch, L. (1992). FIS-dependent trans activation of stable RNA operons of Escherichia coli under various growth conditions. J Bacteriol 174, 921–929.
Paul, B. J., Ross, W., Gaal, T. & Gourse, R. L. (2004). rRNA transcription in Escherichia coli. Annu Rev Genet 38, 749–770.[CrossRef][Medline]
Pemberton, I. K., Muskhelishvili, G., Travers, A. A. & Buckle, M. (2002). FIS modulates the kinetics of successive interactions of RNA polymerase with the core and upstream regions of the tyrT promoter. J Mol Biol 318, 651–663.[CrossRef][Medline]
Quandt, K., Frech, K., Karas, H., Wingender, E. & Werner, T. (1995). MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23, 4878–4884.
Rao, L., Ross, W., Appleman, J. A., Gaal, T., Leirmo, S., Schlax, P. J., Record, M. T., Jr & Gourse, R. L. (1994). Factor independent activation of rrnB P1. An "extended" promoter with an upstream element that dramatically increases promoter strength. J Mol Biol 235, 1421–1435.[CrossRef][Medline]
Ross, W., Thompson, J. F., Newlands, J. T. & Gourse, R. L. (1990). Escherichia coli Fis protein activates ribosomal RNA transcription in vitro and in vivo. EMBO J 9, 3733–3742.[Medline]
Ross, W., Aiyar, S. E., Salomon, J. & Gourse, R. L. (1998). Escherichia coli promoters with UP elements of different strengths: modular structure of bacterial promoters. J Bacteriol 180, 5375–5383.
Ross, W., Salomon, J., Holmes, W. M. & Gourse, R. L. (1999). Activation of Escherichia coli leuV transcription by FIS. J Bacteriol 181, 3864–3868.
Schneider, R., Travers, A. & Muskhelishvili, G. (1997). FIS modulates growth phase-dependent topological transitions of DNA in Escherichia coli. Mol Microbiol 26, 519–530.[CrossRef][Medline]
Shao, Y., Feldman-Cohen, L. S. & Osuna, R. (2008). Functional characterisation of the Escherichia coli Fis-DNA binding sequence. J Mol Biol 376, 771–785.[Medline]
Shultzaberger, R. K., Roberts, L. R., Lyakhov, I. G., Sidorov, I. A., Stephen, A. G., Fisher, R. J. & Schneider, T. D. (2007). Correlation between binding rate constants and individual information of E. coli Fis binding sites. Nucleic Acids Res 35, 5275–5283.
Simons, R. W., Houman, F. & Kleckner, N. (1987). Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53, 85–96.[CrossRef][Medline]
Tesfa-Selase, F. & Drabble, W. T. (1996). Specific binding of DnaA protein to a DnaA box in the guaB gene of Escherichia coli K12. Eur J Biochem 241, 411–416.[Medline]
Tiedeman, A. A. & Smith, J. M. (1984). Isolation and characterization of regulatory mutations affecting the expression of the guaBA operon of Escherichia coli K-12. Mol Gen Genet 195, 77–82.[CrossRef][Medline]
Travers, A., Schneider, R. & Muskhelishvili, G. (2001). DNA supercoiling and transcription in Escherichia coli: the FIS connection. Biochimie 83, 213–217.[Medline]
Weinstein-Fischer, D., Elgrably-Weiss, M. & Altuvia, S. (2000). Escherichia coli response to hydrogen peroxide: a role for DNA supercoiling, topoisomerase I and Fis. Mol Microbiol 35, 1413–1420.[CrossRef][Medline]
Wu, H., Tyson, K. L., Cole, J. A. & Busby, S. J. W. (1998). Regulation of transcription initiation at the Escherichia coli nir operon promoter: a new mechanism to account for co-dependence on two transcription factors. Mol Microbiol 27, 493–505.[CrossRef][Medline]
Received 20 January 2008;
revised 5 March 2008;
accepted 12 March 2008.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY |